uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q59.1606 | Q59 | What is the genetic target of the small molecule drug Org-25935, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Org-25935 is SLC6A9. Org-25935 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%org-25935%" OR LOWER(tradeNames_string) LIKE "%org-25935%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1257', 'drugName': 'Org-25935', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A9 (ENSG00000196517)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1743 | Q59 | What is the genetic target of the small molecule drug Bepotastine Besylate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bepotastine Besylate is HRH1. Bepotastine Besylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bepotastine besylate%" OR LOWER(tradeNames_string) LIKE "%bepotastin... | [{'UUID': 'DrugGeneTargets_v2_3215', 'drugName': 'Bepotastine Besylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.50 | Q59 | What is the genetic target of the antibody drug Cabiralizumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Cabiralizumab is CSF1R. Cabiralizumab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cabiralizumab%" OR LOWER(tradeNames_string) LIKE "%cabiralizumab%" O... | [{'UUID': 'DrugGeneTargets_v2_2114', 'drugName': 'Cabiralizumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CSF1R (ENSG00000182578)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1089 | Q59 | What is the genetic target of the small molecule drug Levosalbutamol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Levosalbutamol is ADRB2. Levosalbutamol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%levosalbutamol%" OR LOWER(tradeNames_string) LIKE "%levosalbutamol%"... | [{'UUID': 'DrugGeneTargets_v2_3721', 'drugName': 'Levosalbutamol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1999, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2058', 'drugName': 'Levalbuterol Tartrate', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1674 | Q59 | What is the genetic target of the small molecule drug Thalidomide, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Thalidomide: CRBN, DDB1, CUL4A, and RBX1. Thalidomide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%thalidomide%" OR LOWER(tradeNames_string) LIKE "%thalidomide%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_64', 'drugName': 'Thalidomide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CRBN (ENSG00000113851), DDB1 (ENSG00000167986), CUL4A (ENSG00000139842), RBX1 (ENSG00000100387)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1697 | Q59 | What is the genetic target of the small molecule drug Metaraminol Bitartrate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Metaraminol Bitartrate: ADRA1A, ADRA1D, and ADRA1B. Metaraminol Bitartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%metaraminol bitartrate%" OR LOWER(tradeNames_string) LIKE "%metarami... | [{'UUID': 'DrugGeneTargets_v2_1846', 'drugName': 'Metaraminol Bitartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214)', 'yearOfFirstApproval': 1954, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.686 | Q59 | What is the genetic target of the small molecule drug Sarpogrelate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Sarpogrelate is HTR2A. Sarpogrelate reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sarpogrelate%" OR LOWER(tradeNames_string) LIKE "%sarpogrelate%" OR ... | [{'UUID': 'DrugGeneTargets_v2_6172', 'drugName': 'Sarpogrelate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1485 | Q59 | What is the genetic target of the small molecule drug Tubocurarine Chloride, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Tubocurarine Chloride: CHRNA1, CHRNG, CHRNB1, CHRND, and CHRNE. Tubocurarine Chloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tubocurarine chloride%" OR LOWER(tradeNames_string) LIKE "%tubocurar... | [{'UUID': 'DrugGeneTargets_v2_5100', 'drugName': 'Tubocurarine Chloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNA1 (ENSG00000138435), CHRNG (ENSG00000196811), CHRNB1 (ENSG00000170175), CHRND (ENSG00000135902), CHRNE (ENSG00000108556)', 'yearOfFirstApproval': 1945, 'maxClinicalTrialPhase... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1455 | Q59 | What is the genetic target of the small molecule drug Ipragliflozin L-Proline, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ipragliflozin L-Proline is SLC5A2. Ipragliflozin L-Proline reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ipragliflozin l-proline%" OR LOWER(tradeNames_string) LIKE "%ipragli... | [{'UUID': 'DrugGeneTargets_v2_2404', 'drugName': 'Ipragliflozin L-Proline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC5A2 (ENSG00000140675)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1486 | Q59 | What is the genetic target of the small molecule drug Halcinonide, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Halcinonide is NR3C1. Halcinonide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%halcinonide%" OR LOWER(tradeNames_string) LIKE "%halcinonide%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5783', 'drugName': 'Halcinonide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1974, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1292 | Q59 | What is the genetic target of the small molecule drug Ipratropium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ipratropium is CHRM3. Ipratropium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ipratropium%" OR LOWER(tradeNames_string) LIKE "%ipratropium%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4927', 'drugName': 'Ipratropium Bromide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019)', 'yearOfFirstApproval': 1986, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3538', 'drugName': 'Ipratropium', 'drugMolec... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1232 | Q59 | What is the genetic target of the small molecule drug Ulipristal, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ulipristal is PGR. Ulipristal reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ulipristal%" OR LOWER(tradeNames_string) LIKE "%ulipristal%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_470', 'drugName': 'Ulipristal', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PGR (ENSG00000082175)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4281', 'drugName': 'Ulipristal Acetate', 'drugMolecularType... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.525 | Q59 | What is the genetic target of the small molecule drug Dicumarol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Dicumarol is VKORC1. Dicumarol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dicumarol%" OR LOWER(tradeNames_string) LIKE "%dicumarol%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1631', 'drugName': 'Dicumarol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'VKORC1 (ENSG00000167397)', 'yearOfFirstApproval': 1944, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1654 | Q59 | What is the genetic target of the small molecule drug Edotecarin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Edotecarin is TOP1. Edotecarin reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%edotecarin%" OR LOWER(tradeNames_string) LIKE "%edotecarin%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1978', 'drugName': 'Edotecarin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TOP1 (ENSG00000198900)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.908 | Q59 | What is the genetic target of the small molecule drug Carmustine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Carmustine is GSR. Carmustine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%carmustine%" OR LOWER(tradeNames_string) LIKE "%carmustine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4261', 'drugName': 'Carmustine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GSR (ENSG00000104687)', 'yearOfFirstApproval': 1977, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1904 | Q59 | What is the genetic target of the small molecule drug Prednisone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Prednisone is NR3C1. Prednisone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%prednisone%" OR LOWER(tradeNames_string) LIKE "%prednisone%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2255', 'drugName': 'Prednisone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1955, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5378', 'drugName': 'Meprednisone', 'drugMolecularType... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1242 | Q59 | What is the genetic target of the small molecule drug Bosutinib, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Bosutinib: ABL1, BCR, HCK, SRC, and LYN. Bosutinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bosutinib%" OR LOWER(tradeNames_string) LIKE "%bosutinib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3958', 'drugName': 'Bosutinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ABL1 (ENSG00000097007), BCR (ENSG00000186716), HCK (ENSG00000101336), SRC (ENSG00000197122), LYN (ENSG00000254087)', 'yearOfFirstApproval': 2010, 'maxClinicalTrialPhase': 4, 'drugIsApproved':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.24 | Q59 | What is the genetic target of the small molecule drug Methimazole, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Methimazole is TPO. Methimazole reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methimazole%" OR LOWER(tradeNames_string) LIKE "%methimazole%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3174', 'drugName': 'Methimazole', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TPO (ENSG00000115705)', 'yearOfFirstApproval': 1950, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.779 | Q59 | What is the genetic target of the small molecule drug Benzydamine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Benzydamine: PTGS2 and PTGS1. Benzydamine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%benzydamine%" OR LOWER(tradeNames_string) LIKE "%benzydamine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3576', 'drugName': 'Benzydamine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1474', 'drugName... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.65 | Q59 | What is the genetic target of the small molecule drug Minodronic Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Minodronic Acid is FDPS. Minodronic Acid reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%minodronic acid%" OR LOWER(tradeNames_string) LIKE "%minodronic acid... | [{'UUID': 'DrugGeneTargets_v2_2268', 'drugName': 'Minodronic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FDPS (ENSG00000160752)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1366 | Q59 | What is the genetic target of the small molecule drug Clobetasol Propionate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Clobetasol Propionate is NR3C1. Clobetasol Propionate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%clobetasol propionate%" OR LOWER(tradeNames_string) LIKE "%clobetaso... | [{'UUID': 'DrugGeneTargets_v2_5376', 'drugName': 'Clobetasol Propionate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.191 | Q59 | What is the genetic target of the antibody drug Caplacizumab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Caplacizumab is VWF. Caplacizumab reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%caplacizumab%" OR LOWER(tradeNames_string) LIKE "%caplacizumab%" OR ... | [{'UUID': 'DrugGeneTargets_v2_5507', 'drugName': 'Caplacizumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'VWF (ENSG00000110799)', 'yearOfFirstApproval': 2019, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1630 | Q59 | What is the genetic target of the antibody drug Yttrium Y 90 Epratuzumab Tetraxetan, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Yttrium Y 90 Epratuzumab Tetraxetan is CD22. Yttrium Y 90 Epratuzumab Tetraxetan reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%yttrium y 90 epratuzumab tetraxetan%" OR LOWER(tradeNames_string) LI... | [{'UUID': 'DrugGeneTargets_v2_1182', 'drugName': 'Yttrium Y 90 Epratuzumab Tetraxetan', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CD22 (ENSG00000012124)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1395 | Q59 | What is the genetic target of the antibody drug Zolimomab Aritox, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Zolimomab Aritox is CD5. Zolimomab Aritox reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%zolimomab aritox%" OR LOWER(tradeNames_string) LIKE "%zolimomab arit... | [{'UUID': 'DrugGeneTargets_v2_4169', 'drugName': 'Zolimomab Aritox', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CD5 (ENSG00000110448)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1547 | Q59 | What is the genetic target of the small molecule drug Indomethacin Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Indomethacin Sodium: PTGS2 and PTGS1. Indomethacin Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%indomethacin sodium%" OR LOWER(tradeNames_string) LIKE "%indomethaci... | [{'UUID': 'DrugGeneTargets_v2_4252', 'drugName': 'Indomethacin Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.346 | Q59 | What is the genetic target of the small molecule drug Ralinepag, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ralinepag is PTGIR. Ralinepag reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ralinepag%" OR LOWER(tradeNames_string) LIKE "%ralinepag%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3547', 'drugName': 'Ralinepag', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGIR (ENSG00000160013)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.400 | Q59 | What is the genetic target of the small molecule drug Norepinephrine, and what is its status in clinical trials and FDA approval? | There are 9 genetic targets of the small molecule drug Norepinephrine: ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2C, ADRA1D, ADRA1B, ADRA2B, and ADRB3. Norepinephrine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%norepinephrine%" OR LOWER(tradeNames_string) LIKE "%norepinephrine%"... | [{'UUID': 'DrugGeneTargets_v2_1992', 'drugName': 'Norepinephrine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRB1 (ENSG00000043591), ADRB2 (ENSG00000169252), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1393 | Q59 | What is the genetic target of the small molecule drug Betamethasone Phosphoric Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Betamethasone Phosphoric Acid is NR3C1. Betamethasone Phosphoric Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%betamethasone phosphoric acid%" OR LOWER(tradeNames_string) LIKE "%b... | [{'UUID': 'DrugGeneTargets_v2_2412', 'drugName': 'Betamethasone Phosphoric Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1965, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1876 | Q59 | What is the genetic target of the small molecule drug Estramustine Phosphate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Estramustine Phosphate is ESR2. Estramustine Phosphate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%estramustine phosphate%" OR LOWER(tradeNames_string) LIKE "%estramus... | [{'UUID': 'DrugGeneTargets_v2_5377', 'drugName': 'Estramustine Phosphate Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ESR2 (ENSG00000140009)', 'yearOfFirstApproval': 1981, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5789', 'drugName': 'Estramustine Ph... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.199 | Q59 | What is the genetic target of the small molecule drug Nilotinib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Nilotinib: ABL1 and BCR. Nilotinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nilotinib%" OR LOWER(tradeNames_string) LIKE "%nilotinib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_6061', 'drugName': 'Nilotinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ABL1 (ENSG00000097007), BCR (ENSG00000186716)', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6060', 'drugName': 'Nilotinib', ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1173 | Q59 | What is the genetic target of the small molecule drug Mk-8777, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Mk-8777: GRIA4, GRIA3, GRIA2, and GRIA1. Mk-8777 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mk-8777%" OR LOWER(tradeNames_string) LIKE "%mk-8777%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_5646', 'drugName': 'Mk-8777', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GRIA4 (ENSG00000152578), GRIA3 (ENSG00000125675), GRIA2 (ENSG00000120251), GRIA1 (ENSG00000155511)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.320 | Q59 | What is the genetic target of the small molecule drug Cep-11981, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Cep-11981: TEK, FLT1, FLT4, and KDR. Cep-11981 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cep-11981%" OR LOWER(tradeNames_string) LIKE "%cep-11981%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4988', 'drugName': 'Cep-11981', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TEK (ENSG00000120156), FLT1 (ENSG00000102755), FLT4 (ENSG00000037280), KDR (ENSG00000128052)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGe... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1002 | Q59 | What is the genetic target of the small molecule drug Bitolterol Mesylate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bitolterol Mesylate is ADRB2. Bitolterol Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bitolterol mesylate%" OR LOWER(tradeNames_string) LIKE "%bitolterol ... | [{'UUID': 'DrugGeneTargets_v2_3535', 'drugName': 'Bitolterol Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.223 | Q59 | What is the genetic target of the small molecule drug Methyldopate Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Methyldopate Hydrochloride: ADRA2A, ADRA2C, and ADRA2B. Methyldopate Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methyldopate hydrochloride%" OR LOWER(tradeNames_string) LIKE "%meth... | [{'UUID': 'DrugGeneTargets_v2_5960', 'drugName': 'Methyldopate Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA2B (ENSG00000274286)', 'yearOfFirstApproval': 1962, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1220 | Q59 | What is the genetic target of the small molecule drug Ibuprofen Lysine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Ibuprofen Lysine: PTGS2 and PTGS1. Ibuprofen Lysine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ibuprofen lysine%" OR LOWER(tradeNames_string) LIKE "%ibuprofen lysi... | [{'UUID': 'DrugGeneTargets_v2_4050', 'drugName': 'Ibuprofen Lysine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 2006, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.103 | Q59 | What is the genetic target of the small molecule drug Cabergoline, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cabergoline is DRD2. Cabergoline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cabergoline%" OR LOWER(tradeNames_string) LIKE "%cabergoline%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4668', 'drugName': 'Cabergoline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1655 | Q59 | What is the genetic target of the small molecule drug Nicotine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Nicotine: CHRNB2 and CHRNA4. Nicotine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nicotine%" OR LOWER(tradeNames_string) LIKE "%nicotine%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_5052', 'drugName': 'Nicotine Polacrilex', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRNB2 (ENSG00000160716), CHRNA4 (ENSG00000101204)', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_687', 'drugName':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.949 | Q59 | What is the genetic target of the small molecule drug Ambenonium Chloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ambenonium Chloride is ACHE. Ambenonium Chloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ambenonium chloride%" OR LOWER(tradeNames_string) LIKE "%ambenonium ... | [{'UUID': 'DrugGeneTargets_v2_150', 'drugName': 'Ambenonium Chloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACHE (ENSG00000087085)', 'yearOfFirstApproval': 1956, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1939 | Q59 | What is the genetic target of the small molecule drug Nortriptyline Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Nortriptyline Hydrochloride: SLC6A2 and SLC6A4. Nortriptyline Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nortriptyline hydrochloride%" OR LOWER(tradeNames_string) LIKE "%nor... | [{'UUID': 'DrugGeneTargets_v2_5991', 'drugName': 'Nortriptyline Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546), SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1964, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5992', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1914 | Q59 | What is the genetic target of the protein drug Fe 202767, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Fe 202767 is OXTR. Fe 202767 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fe 202767%" OR LOWER(tradeNames_string) LIKE "%fe 202767%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1641', 'drugName': 'Fe 202767', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'OXTR (ENSG00000180914)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1127 | Q59 | What is the genetic target of the protein drug Insulin Zinc Susp Extended Recombinant Human, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Insulin Zinc Susp Extended Recombinant Human is INSR. Insulin Zinc Susp Extended Recombinant Human reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%insulin zinc susp extended recombinant human%" OR LOWER(tradeNames_s... | [{'UUID': 'DrugGeneTargets_v2_4713', 'drugName': 'Insulin Zinc Susp Extended Recombinant Human', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'INSR (ENSG00000171105)', 'yearOfFirstApproval': 1987, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1052 | Q59 | What is the genetic target of the small molecule drug Oxymetazoline, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Oxymetazoline: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, and ADRA2B. Oxymetazoline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxymetazoline%" OR LOWER(tradeNames_string) LIKE "%oxymetazoline%" O... | [{'UUID': 'DrugGeneTargets_v2_543', 'drugName': 'Oxymetazoline Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfFirstAppro... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1538 | Q59 | What is the genetic target of the small molecule drug Vorapaxar Sulfate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Vorapaxar Sulfate is F2R. Vorapaxar Sulfate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vorapaxar sulfate%" OR LOWER(tradeNames_string) LIKE "%vorapaxar sul... | [{'UUID': 'DrugGeneTargets_v2_713', 'drugName': 'Vorapaxar Sulfate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'F2R (ENSG00000181104)', 'yearOfFirstApproval': 2014, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.356 | Q59 | What is the genetic target of the small molecule drug Crofelemer, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Crofelemer: CFTR and ANO1. Crofelemer reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%crofelemer%" OR LOWER(tradeNames_string) LIKE "%crofelemer%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2220', 'drugName': 'Crofelemer', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CFTR (ENSG00000001626), ANO1 (ENSG00000131620)', 'yearOfFirstApproval': 2012, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2221', 'drugName': 'Crofelemer... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.603 | Q59 | What is the genetic target of the small molecule drug Salmeterol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Salmeterol is ADRB2. Salmeterol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%salmeterol%" OR LOWER(tradeNames_string) LIKE "%salmeterol%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4540', 'drugName': 'Salmeterol Xinafoate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4770', 'drugName': 'Salmeterol', 'drugMolec... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1559 | Q59 | What is the genetic target of the small molecule drug Faxeladol, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Faxeladol: SLC6A4, SLC6A2, and OPRM1. Faxeladol reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%faxeladol%" OR LOWER(tradeNames_string) LIKE "%faxeladol%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_523', 'drugName': 'Faxeladol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576), SLC6A2 (ENSG00000103546), OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_524',... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1350 | Q59 | What is the genetic target of the small molecule drug Mephentermine Sulfate, and what is its status in clinical trials and FDA approval? | There are 9 genetic targets of the small molecule drug Mephentermine Sulfate: ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2C, ADRA1D, ADRA1B, ADRA2B, and ADRB3. Mephentermine Sulfate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%mephentermine sulfate%" OR LOWER(tradeNames_string) LIKE "%mephenter... | [{'UUID': 'DrugGeneTargets_v2_4285', 'drugName': 'Mephentermine Sulfate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRB1 (ENSG00000043591), ADRB2 (ENSG00000169252), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214),... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1359 | Q59 | What is the genetic target of the small molecule drug Chlorpromazine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Chlorpromazine Hydrochloride: DRD2, DRD3, DRD4, and HTR2A. Chlorpromazine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%chlorpromazine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%ch... | [{'UUID': 'DrugGeneTargets_v2_2783', 'drugName': 'Chlorpromazine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696), HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 1957, 'maxClinicalTrialPhase': 4, 'drugIsApproved':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.947 | Q59 | What is the genetic target of the small molecule drug Cp-866087, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cp-866087 is OPRM1. Cp-866087 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cp-866087%" OR LOWER(tradeNames_string) LIKE "%cp-866087%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3407', 'drugName': 'Cp-866087', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.348 | Q59 | What is the genetic target of the antibody drug Icm3, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Icm3 is ICAM3. Icm3 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%icm3%" OR LOWER(tradeNames_string) LIKE "%icm3%" OR LOWER(drugSynony... | [{'UUID': 'DrugGeneTargets_v2_1930', 'drugName': 'Icm3', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'ICAM3 (ENSG00000076662)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.606 | Q59 | What is the genetic target of the small molecule drug Alseroxylon, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Alseroxylon: ADRA1A, ADRA2A, ADRA2C, ADRA1D, ADRA1B, and ADRA2B. Alseroxylon reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alseroxylon%" OR LOWER(tradeNames_string) LIKE "%alseroxylon%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4856', 'drugName': 'Rauwolfia Serpentina', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG00000170214), ADRA2B (ENSG00000274286)', 'yearOfFirstApproval': ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.719 | Q59 | What is the genetic target of the small molecule drug Benazepril, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Benazepril is ACE. Benazepril reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%benazepril%" OR LOWER(tradeNames_string) LIKE "%benazepril%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5353', 'drugName': 'Benazepril Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACE (ENSG00000159640)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5259', 'drugName': 'Benazepril', 'drugMol... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.118 | Q59 | What is the genetic target of the small molecule drug Alfentanil, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Alfentanil is OPRM1. Alfentanil reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alfentanil%" OR LOWER(tradeNames_string) LIKE "%alfentanil%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_793', 'drugName': 'Alfentanil Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 1986, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2019', 'drugName': 'Alfentanil', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.617 | Q59 | What is the genetic target of the small molecule drug Carboprost, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Carboprost is PTGFR. Carboprost reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%carboprost%" OR LOWER(tradeNames_string) LIKE "%carboprost%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2928', 'drugName': 'Carboprost Tromethamine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGFR (ENSG00000122420)', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5593', 'drugName': 'Carboprost', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1013 | Q59 | What is the genetic target of the small molecule drug Clidinium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Clidinium: CHRM3 and CHRM1. Clidinium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%clidinium%" OR LOWER(tradeNames_string) LIKE "%clidinium%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_73', 'drugName': 'Clidinium Bromide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019), CHRM1 (ENSG00000168539)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4584', 'drugName': 'Cli... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1265 | Q59 | What is the genetic target of the small molecule drug Tabimorelin, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Tabimorelin: GHSR and CYP3A4. Tabimorelin reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tabimorelin%" OR LOWER(tradeNames_string) LIKE "%tabimorelin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5300', 'drugName': 'Tabimorelin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GHSR (ENSG00000121853), CYP3A4 (ENSG00000160868)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_5301', 'drugName': 'Tabimorel... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1489 | Q59 | What is the genetic target of the small molecule drug Diethylpropion Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Diethylpropion Hydrochloride: SLC6A2 and SLC6A3. Diethylpropion Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diethylpropion hydrochloride%" OR LOWER(tradeNames_string) LIKE "%di... | [{'UUID': 'DrugGeneTargets_v2_2343', 'drugName': 'Diethylpropion Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546), SLC6A3 (ENSG00000142319)', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2344', '... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.489 | Q59 | What is the genetic target of the small molecule drug Cyclopentolate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cyclopentolate is CHRM3. Cyclopentolate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cyclopentolate%" OR LOWER(tradeNames_string) LIKE "%cyclopentolate%"... | [{'UUID': 'DrugGeneTargets_v2_5172', 'drugName': 'Cyclopentolate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019)', 'yearOfFirstApproval': 1974, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6338', 'drugName': 'Cyclopentolate Hydrochloride'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1711 | Q59 | What is the genetic target of the small molecule drug Tripelennamine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Tripelennamine Hydrochloride is HRH1. Tripelennamine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tripelennamine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%tr... | [{'UUID': 'DrugGeneTargets_v2_5081', 'drugName': 'Tripelennamine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1948, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.787 | Q59 | What is the genetic target of the small molecule drug Timolol Maleate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Timolol Maleate: ADRB2 and ADRB1. Timolol Maleate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%timolol maleate%" OR LOWER(tradeNames_string) LIKE "%timolol maleate... | [{'UUID': 'DrugGeneTargets_v2_760', 'drugName': 'Timolol Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252), ADRB1 (ENSG00000043591)', 'yearOfFirstApproval': 1978, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_761', 'drugName': 'Timol... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.881 | Q59 | What is the genetic target of the antibody drug Medi-500, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the antibody drug Medi-500: TRAV29DV5, TRAC, TRBV7-9, and TRGV3. Medi-500 reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%medi-500%" OR LOWER(tradeNames_string) LIKE "%medi-500%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_1483', 'drugName': 'Medi-500', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'TRAV29DV5 (ENSG00000211810), TRAC (ENSG00000277734), TRBV7-9 (ENSG00000278030), TRGV3 (ENSG00000211699)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1555 | Q59 | What is the genetic target of the protein drug Lanreotide, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the protein drug Lanreotide: SSTR5 and SSTR2. Lanreotide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lanreotide%" OR LOWER(tradeNames_string) LIKE "%lanreotide%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2627', 'drugName': 'Lanreotide Acetate', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'SSTR5 (ENSG00000162009), SSTR2 (ENSG00000180616)', 'yearOfFirstApproval': 2007, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2626', 'drugName': 'Lanreot... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.567 | Q59 | What is the genetic target of the small molecule drug Tas-115, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Tas-115: MET and KDR. Tas-115 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tas-115%" OR LOWER(tradeNames_string) LIKE "%tas-115%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_532', 'drugName': 'Tas-115', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MET (ENSG00000105976), KDR (ENSG00000128052)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_533', 'drugName': 'Tas-115', 'drugMole... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.254 | Q59 | What is the genetic target of the small molecule drug Loratadine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Loratadine is HRH1. Loratadine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%loratadine%" OR LOWER(tradeNames_string) LIKE "%loratadine%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1956', 'drugName': 'Loratadine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1993, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3239', 'drugName': 'Desloratadine', 'drugMolecularType... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.242 | Q59 | What is the genetic target of the small molecule drug Av-101, and what is its status in clinical trials and FDA approval? | There are 7 genetic targets of the small molecule drug Av-101: GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3B, GRIN2C, and GRIN3A. Av-101 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%av-101%" OR LOWER(tradeNames_string) LIKE "%av-101%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_4732', 'drugName': 'Av-101', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GRIN1 (ENSG00000176884), GRIN2A (ENSG00000183454), GRIN2B (ENSG00000273079), GRIN2D (ENSG00000105464), GRIN3B (ENSG00000116032), GRIN2C (ENSG00000161509), GRIN3A (ENSG00000198785)', 'yearOfFirst... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.176 | Q59 | What is the genetic target of the protein drug Glucagon, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Glucagon is GCGR. Glucagon reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%glucagon%" OR LOWER(tradeNames_string) LIKE "%glucagon%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_1857', 'drugName': 'Glucagon', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GCGR (ENSG00000215644)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4736', 'drugName': 'Dasiglucagon Hydrochloride', 'drugMolecular... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.824 | Q59 | What is the genetic target of the small molecule drug Methysergide Maleate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Methysergide Maleate: HTR2C, HTR2B, and HTR1A. Methysergide Maleate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methysergide maleate%" OR LOWER(tradeNames_string) LIKE "%methysergi... | [{'UUID': 'DrugGeneTargets_v2_2806', 'drugName': 'Methysergide Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2C (ENSG00000147246), HTR2B (ENSG00000135914), HTR1A (ENSG00000178394)', 'yearOfFirstApproval': 1962, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTarg... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.983 | Q59 | What is the genetic target of the small molecule drug Xanomeline, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Xanomeline: CHRM1 and CHRM4. Xanomeline reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%xanomeline%" OR LOWER(tradeNames_string) LIKE "%xanomeline%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3335', 'drugName': 'Xanomeline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM1 (ENSG00000168539), CHRM4 (ENSG00000180720)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_3336', 'drugName': 'Xanomeline... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1476 | Q59 | What is the genetic target of the small molecule drug Anastrozole, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Anastrozole is CYP19A1. Anastrozole reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anastrozole%" OR LOWER(tradeNames_string) LIKE "%anastrozole%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3640', 'drugName': 'Anastrozole', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CYP19A1 (ENSG00000137869)', 'yearOfFirstApproval': 1995, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1262 | Q59 | What is the genetic target of the small molecule drug Ivosidenib, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ivosidenib is IDH1. Ivosidenib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ivosidenib%" OR LOWER(tradeNames_string) LIKE "%ivosidenib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1675', 'drugName': 'Ivosidenib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'IDH1 (ENSG00000138413)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1280 | Q59 | What is the genetic target of the small molecule drug Ripasudil Hydrochloride Dihydrate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Ripasudil Hydrochloride Dihydrate: ROCK2 and ROCK1. Ripasudil Hydrochloride Dihydrate reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ripasudil hydrochloride dihydrate%" OR LOWER(tradeNames_string) LIKE... | [{'UUID': 'DrugGeneTargets_v2_3111', 'drugName': 'Ripasudil Hydrochloride Dihydrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ROCK2 (ENSG00000134318), ROCK1 (ENSG00000067900)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.751 | Q59 | What is the genetic target of the small molecule drug Flavoxate Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 8 genetic targets of the small molecule drug Flavoxate Hydrochloride: PDE8B, PDE8A, PDE7A, PDE7B, PDE4A, PDE4D, PDE4B, and PDE4C. Flavoxate Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%flavoxate hydrochloride%" OR LOWER(tradeNames_string) LIKE "%flavoxa... | [{'UUID': 'DrugGeneTargets_v2_1987', 'drugName': 'Flavoxate Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE8B (ENSG00000113231), PDE8A (ENSG00000073417), PDE7A (ENSG00000205268), PDE7B (ENSG00000171408), PDE4A (ENSG00000065989), PDE4D (ENSG00000113448), PDE4B (ENSG00000184588), PD... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.561 | Q59 | What is the genetic target of the small molecule drug Adenosine, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Adenosine: ADORA1, ADORA2B, ADORA3, and ADORA2A. Adenosine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%adenosine%" OR LOWER(tradeNames_string) LIKE "%adenosine%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1105', 'drugName': 'Adenosine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADORA1 (ENSG00000163485), ADORA2B (ENSG00000170425), ADORA3 (ENSG00000282608), ADORA2A (ENSG00000128271)', 'yearOfFirstApproval': 1989, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.81 | Q59 | What is the genetic target of the small molecule drug Azelastine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azelastine Hydrochloride is HRH1. Azelastine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azelastine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%azelas... | [{'UUID': 'DrugGeneTargets_v2_3567', 'drugName': 'Azelastine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1042 | Q59 | What is the genetic target of the small molecule drug Chlorothiazide Sodium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Chlorothiazide Sodium is SLC12A3. Chlorothiazide Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%chlorothiazide sodium%" OR LOWER(tradeNames_string) LIKE "%chlorothi... | [{'UUID': 'DrugGeneTargets_v2_5405', 'drugName': 'Chlorothiazide Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC12A3 (ENSG00000070915)', 'yearOfFirstApproval': 1958, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1314 | Q59 | What is the genetic target of the protein drug Cosyntropin, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Cosyntropin is MC2R. Cosyntropin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cosyntropin%" OR LOWER(tradeNames_string) LIKE "%cosyntropin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4137', 'drugName': 'Cosyntropin', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'MC2R (ENSG00000185231)', 'yearOfFirstApproval': 1970, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.33 | Q59 | What is the genetic target of the small molecule drug Quinapril Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Quinapril Hydrochloride is ACE. Quinapril Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%quinapril hydrochloride%" OR LOWER(tradeNames_string) LIKE "%quinapr... | [{'UUID': 'DrugGeneTargets_v2_1269', 'drugName': 'Quinapril Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACE (ENSG00000159640)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1739 | Q59 | What is the genetic target of the small molecule drug Dovitinib, and what is its status in clinical trials and FDA approval? | There are 8 genetic targets of the small molecule drug Dovitinib: PDGFRB, PDGFRA, KIT, FLT3, FGFR3, FLT1, FLT4, and KDR. Dovitinib reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dovitinib%" OR LOWER(tradeNames_string) LIKE "%dovitinib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_5744', 'drugName': 'Dovitinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), KIT (ENSG00000157404), FLT3 (ENSG00000122025), FGFR3 (ENSG00000068078), FLT1 (ENSG00000102755), FLT4 (ENSG00000037280), KDR (ENSG0000012805... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.358 | Q59 | What is the genetic target of the small molecule drug Gw-406381, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Gw-406381 is PTGS2. Gw-406381 reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gw-406381%" OR LOWER(tradeNames_string) LIKE "%gw-406381%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3746', 'drugName': 'Gw-406381', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1077 | Q59 | What is the genetic target of the small molecule drug Benzhydrocodone, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Benzhydrocodone: OPRK1, OPRD1, and OPRM1. Benzhydrocodone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%benzhydrocodone%" OR LOWER(tradeNames_string) LIKE "%benzhydrocodone... | [{'UUID': 'DrugGeneTargets_v2_529', 'drugName': 'Benzhydrocodone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRK1 (ENSG00000082556), OPRD1 (ENSG00000116329), OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1692 | Q59 | What is the genetic target of the small molecule drug Vonoprazan, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Vonoprazan: ATP4A and ATP4B. Vonoprazan reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vonoprazan%" OR LOWER(tradeNames_string) LIKE "%vonoprazan%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5640', 'drugName': 'Vonoprazan Fumarate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 2022, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5499', 'drugName': ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.127 | Q59 | What is the genetic target of the small molecule drug Hydrocodone, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Hydrocodone: OPRK1, OPRD1, and OPRM1. Hydrocodone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hydrocodone%" OR LOWER(tradeNames_string) LIKE "%hydrocodone%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3008', 'drugName': 'Benzhydrocodone Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRK1 (ENSG00000082556), OPRD1 (ENSG00000116329), OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'Dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1031 | Q59 | What is the genetic target of the antibody drug Amg-729, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Amg-729 is CD19. Amg-729 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%amg-729%" OR LOWER(tradeNames_string) LIKE "%amg-729%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_1055', 'drugName': 'Amg-729', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'CD19 (ENSG00000177455)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.399 | Q59 | What is the genetic target of the small molecule drug Levothyroxine Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Levothyroxine Sodium: THRA and THRB. Levothyroxine Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%levothyroxine sodium%" OR LOWER(tradeNames_string) LIKE "%levothyrox... | [{'UUID': 'DrugGeneTargets_v2_83', 'drugName': 'Liothyronine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'THRA (ENSG00000126351), THRB (ENSG00000151090)', 'yearOfFirstApproval': 1956, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5964', 'drugName': 'Levothyrox... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.444 | Q59 | What is the genetic target of the small molecule drug Valproic Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Valproic Acid is ALDH5A1. Valproic Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%valproic acid%" OR LOWER(tradeNames_string) LIKE "%valproic acid%" O... | [{'UUID': 'DrugGeneTargets_v2_6237', 'drugName': 'Valproic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ALDH5A1 (ENSG00000112294)', 'yearOfFirstApproval': 1978, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5683', 'drugName': 'Divalproex Sodium', 'drugMol... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.166 | Q59 | What is the genetic target of the small molecule drug Trazodone Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Trazodone Hydrochloride: HTR2A, HTR2C, and SLC6A4. Trazodone Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trazodone hydrochloride%" OR LOWER(tradeNames_string) LIKE "%trazodo... | [{'UUID': 'DrugGeneTargets_v2_4975', 'drugName': 'Trazodone Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2A (ENSG00000102468), HTR2C (ENSG00000147246), SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1981, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGene... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.206 | Q59 | What is the genetic target of the small molecule drug Alclometasone Dipropionate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Alclometasone Dipropionate is NR3C1. Alclometasone Dipropionate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alclometasone dipropionate%" OR LOWER(tradeNames_string) LIKE "%alcl... | [{'UUID': 'DrugGeneTargets_v2_2070', 'drugName': 'Alclometasone Dipropionate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1571 | Q59 | What is the genetic target of the small molecule drug Gaboxadol, and what is its status in clinical trials and FDA approval? | There are 9 genetic targets of the small molecule drug Gaboxadol: GABRA1, GABRB2, GABRB3, GABRA4, GABRA3, GABRB1, GABRA2, GABRA5, and GABRA6. Gaboxadol reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gaboxadol%" OR LOWER(tradeNames_string) LIKE "%gaboxadol%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_3615', 'drugName': 'Gaboxadol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GABRA1 (ENSG00000022355), GABRB2 (ENSG00000145864), GABRB3 (ENSG00000166206), GABRA4 (ENSG00000109158), GABRA3 (ENSG00000011677), GABRB1 (ENSG00000163288), GABRA2 (ENSG00000151834), GABRA5 (E... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1641 | Q59 | What is the genetic target of the small molecule drug Iloperidone, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Iloperidone: DRD2 and HTR2A. Iloperidone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%iloperidone%" OR LOWER(tradeNames_string) LIKE "%iloperidone%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4312', 'drugName': 'Iloperidone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 2009, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4313', 'drugName': 'Iloperid... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1565 | Q59 | What is the genetic target of the small molecule drug Azilsartan Medoxomil, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azilsartan Medoxomil is AGTR1. Azilsartan Medoxomil reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azilsartan medoxomil%" OR LOWER(tradeNames_string) LIKE "%azilsartan... | [{'UUID': 'DrugGeneTargets_v2_5498', 'drugName': 'Azilsartan Medoxomil', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AGTR1 (ENSG00000144891)', 'yearOfFirstApproval': 2011, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1209', 'drugName': 'Azilsartan Kamedoxomil'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.491 | Q59 | What is the genetic target of the small molecule drug Sr16234, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Sr16234 is ESR1. Sr16234 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sr16234%" OR LOWER(tradeNames_string) LIKE "%sr16234%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_534', 'drugName': 'Sr16234', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ESR1 (ENSG00000091831)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_5832', 'drugName': 'Sr16234', 'drugMolecularType': 'Small mo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1966 | Q59 | What is the genetic target of the small molecule drug Sunitinib Malate, and what is its status in clinical trials and FDA approval? | There are 9 genetic targets of the small molecule drug Sunitinib Malate: PDGFRB, PDGFRA, RET, FLT1, FLT4, KDR, CSF1R, FLT3, and KIT. Sunitinib Malate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sunitinib malate%" OR LOWER(tradeNames_string) LIKE "%sunitinib mala... | [{'UUID': 'DrugGeneTargets_v2_3923', 'drugName': 'Sunitinib Malate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853), RET (ENSG00000165731), FLT1 (ENSG00000102755), FLT4 (ENSG00000037280), KDR (ENSG00000128052), CSF1R (ENSG00000182578), FLT3 (ENSG000... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1800 | Q59 | What is the genetic target of the small molecule drug Debrisoquin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Debrisoquin is SLC6A2. Debrisoquin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%debrisoquin%" OR LOWER(tradeNames_string) LIKE "%debrisoquin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_964', 'drugName': 'Debrisoquin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1330 | Q59 | What is the genetic target of the small molecule drug Miglitol, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Miglitol: MGAM and GAA. Miglitol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%miglitol%" OR LOWER(tradeNames_string) LIKE "%miglitol%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_1114', 'drugName': 'Miglitol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MGAM (ENSG00000257335), GAA (ENSG00000171298)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1115', 'drugName': 'Miglitol', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.285 | Q59 | What is the genetic target of the small molecule drug Amitriptyline, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Amitriptyline: SLC6A2 and SLC6A4. Amitriptyline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%amitriptyline%" OR LOWER(tradeNames_string) LIKE "%amitriptyline%" O... | [{'UUID': 'DrugGeneTargets_v2_598', 'drugName': 'Nortriptyline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576), SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 1964, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1624', 'drugName': 'Amit... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1375 | Q59 | What is the genetic target of the small molecule drug Echothiophate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Echothiophate is ACHE. Echothiophate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%echothiophate%" OR LOWER(tradeNames_string) LIKE "%echothiophate%" O... | [{'UUID': 'DrugGeneTargets_v2_2260', 'drugName': 'Echothiophate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACHE (ENSG00000087085)', 'yearOfFirstApproval': 1960, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2129', 'drugName': 'Echothiophate Iodide', 'drugMol... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.221 | Q59 | What is the genetic target of the small molecule drug Copanlisib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Copanlisib: PIK3CA and PIK3CD. Copanlisib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%copanlisib%" OR LOWER(tradeNames_string) LIKE "%copanlisib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2314', 'drugName': 'Copanlisib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PIK3CA (ENSG00000121879), PIK3CD (ENSG00000171608)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2313', 'drugName': 'Copanl... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1931 | Q59 | What is the genetic target of the small molecule drug Revefenacin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Revefenacin is CHRM3. Revefenacin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%revefenacin%" OR LOWER(tradeNames_string) LIKE "%revefenacin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4223', 'drugName': 'Revefenacin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.888 | Q59 | What is the genetic target of the small molecule drug Fomepizole, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Fomepizole: ADH1A, ADH1B, and ADH1C. Fomepizole reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fomepizole%" OR LOWER(tradeNames_string) LIKE "%fomepizole%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_1663', 'drugName': 'Fomepizole', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADH1A (ENSG00000187758), ADH1B (ENSG00000196616), ADH1C (ENSG00000248144)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1623 | Q59 | What is the genetic target of the small molecule drug Latanoprostene Bunod, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Latanoprostene Bunod is PTGFR. Latanoprostene Bunod reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%latanoprostene bunod%" OR LOWER(tradeNames_string) LIKE "%latanopros... | [{'UUID': 'DrugGeneTargets_v2_2312', 'drugName': 'Latanoprostene Bunod', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGFR (ENSG00000122420)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.